BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 16614709)

  • 21. Circadian variations of interferon-induced enhancement of human natural killer (NK) cell activity.
    Gatti G; Cavallo R; Sartori ML; Carignola R; Masera R; Delponte D; Salvadori A; Angeli A
    Cancer Detect Prev; 1988; 12(1-6):431-8. PubMed ID: 3141053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian changes in human natural killer-cell activity.
    Gatti G; Del Ponte D; Cavallo R; Sartori ML; Salvadori A; Carignola R; Carandente F; Angeli A
    Prog Clin Biol Res; 1987; 227A():399-409. PubMed ID: 3299388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal ethanol exposure disrupts the daily rhythms of splenic granzyme B, IFN-gamma, and NK cell cytotoxicity in adulthood.
    Arjona A; Boyadjieva N; Kuhn P; Sarkar DK
    Alcohol Clin Exp Res; 2006 Jun; 30(6):1039-44. PubMed ID: 16737463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
    Karavodin LM; Golub SH
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Circulating K and NK cells in malignant melanoma using monoclonal antibodies].
    Graul A; Orfanos CE
    Z Hautkr; 1985 Feb; 60(4):338-47. PubMed ID: 3984439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Functional activity of the natural killers and macrophages in patients with breast tumors].
    Andrianov IG; Voronov SM; Dobkin AN; Okulov VB; Orlov AB
    Vopr Onkol; 1988; 34(12):1455-60. PubMed ID: 3265236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cells.
    Itoh K; Tilden AB; Balch CM
    Cancer Res; 1985 Jul; 45(7):3173-8. PubMed ID: 3924397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum.
    Lauer SJ; Finlan J; Borella LD; Piaskowski VD; Casper JT
    J Clin Lab Immunol; 1983 Oct; 12(2):105-10. PubMed ID: 6606047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R; Nagler A
    Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of human NK cell activity by cultured cells. II Ingestion of aspirin by blood donors suppresses induced NK activity.
    Grohmann PH; Porzsolt F; Quirt I; Miller RG; Phillips RA
    Clin Exp Immunol; 1981 Jun; 44(3):611-4. PubMed ID: 7326871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.
    Park YW; Kee SJ; Cho YN; Lee EH; Lee HY; Kim EM; Shin MH; Park JJ; Kim TJ; Lee SS; Yoo DH; Kang HS
    Arthritis Rheum; 2009 Jun; 60(6):1753-63. PubMed ID: 19479851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seasonal modulation of the circadian time structure of circulating T and natural killer lymphocyte subsets from healthy subjects.
    Lévi FA; Canon C; Touitou Y; Reinberg A; Mathé G
    J Clin Invest; 1988 Feb; 81(2):407-13. PubMed ID: 3257498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian rhythm of natural killer cell activity in vitiligo.
    Mozzanica N; Frigerio U; Negri M; Tadini G; Villa ML; Mantovani M; Finzi AF
    J Am Acad Dermatol; 1989 Apr; 20(4):591-6. PubMed ID: 2715406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platform-independent estimation of human physiological time from single blood samples.
    Huang Y; Braun R
    Proc Natl Acad Sci U S A; 2024 Jan; 121(3):e2308114120. PubMed ID: 38190520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why does circadian timing of administration matter for immune checkpoint inhibitors' efficacy?
    Karaboué A; Innominato PF; Wreglesworth NI; Duchemann B; Adam R; Lévi FA
    Br J Cancer; 2024 Jun; ():. PubMed ID: 38834742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Circadian Gene NPAS2 Act as a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma.
    Zheng X; Lv X; Zhu L; Xu K; Shi C; Cui L; Ding H
    Cancer Manag Res; 2021; 13():9329-9343. PubMed ID: 34992456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health effects of a forest environment on natural killer cells in humans: an observational pilot study.
    Tsao TM; Tsai MJ; Hwang JS; Cheng WF; Wu CF; Chou CK; Su TC
    Oncotarget; 2018 Mar; 9(23):16501-16511. PubMed ID: 29662662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Running for time: circadian rhythms and melanoma.
    Markova-Car EP; Jurišić D; Ilić N; Kraljević Pavelić S
    Tumour Biol; 2014 Sep; 35(9):8359-68. PubMed ID: 24729125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.